Ozempic vs Wegovy: Which Costs Less?

Published 2026-07-01 · Updated 2026-07-08 · MetaDose Research

Free comparison

Compare GLP-1 providers & cash-pay options

See telehealth and pharmacy programs that may lower your monthly cost.

MetaDose may earn a fee through partner links. See our disclaimer.

Both Ozempic and Wegovy use semaglutide, but manufacturer list prices differ. In 2026, Ozempic lists around $969/month and Wegovy around $1,349/month — yet many patients pay $25–$100 with commercial insurance and savings cards.

Why list prices differ

Ozempic (diabetes) and Wegovy (obesity) are separate FDA indications with different dosing and packaging. Insurers treat them differently on formularies.

Insurance coverage patterns

Commercial plans more often cover Ozempic for diabetes. Weight-loss coverage for Wegovy or Zepbound frequently requires prior authorization and BMI documentation.

How to compare your cost

Use the MetaDose GLP-1 calculator with your state, insurance type, and savings card eligibility for a personalized estimate.

GLP-1 cost by state

Frequently Asked Questions

Is Ozempic cheaper than Wegovy?

Ozempic often has a lower list price because it is marketed for Type 2 diabetes. Wegovy is approved for weight loss and typically lists higher, though your out-of-pocket cost depends on insurance.

Can I use Ozempic for weight loss instead of Wegovy?

Only if prescribed by your doctor. Insurance may not cover off-label use. Do not switch medications without medical guidance.

Related tools & pages

More GLP-1 guides

View all 43 guides →